2021, Number 2
<< Back Next >>
Revista Cubana de Angiología y Cirugía Vascular 2021; 22 (2)
Infections associated with health care at the National Institute of Angiology and Vascular Surgery
Rodríguez ÁVM, Hernández SA
Language: Spanish
References: 23
Page: 1-13
PDF size: 472.62 Kb.
ABSTRACT
Introduction:
Health care associated infections are a health problem.
Objective:
Characterize healthcare associated infections in the three services of the National Institute of Angiology and Vascular Surgery during 2019.
Methods:
Longitudinal study of clinical epidemiology in 89 patients admitted in 2019, who were diagnosed with an infection associated with health care. The study variables were: age, sex, months of the year, care service, associated diseases, more frequent germs and main locations. Absolute and relative frequencies were calculated.
Results:
A cumulative percentage rate of 6.6 per 100 discharges was found, with male predominance and higher frequency in patients in the fifth decade of life. The surgical wound was present in 43 of the 89 cases reported, followed by bacterial bronchopneumonie with 18. The main associated disease was diabetes mellitus and the most common isolated germs were Stafilococus aureus, Pseudomonasp and Acinetobacter baumannii.
Conclusions:
The incidence rate of healthcare associated infections at the National Institute of Angiology and Vascular Surgery during 2019 does not differ from those presented in previous years and corresponds to international reports.
REFERENCES
Gallardo Pérez U, García Pérez A. Incidencia de las infecciones intra-hospitalarias en los servicios de Angiología. Rev Cubana Angiol y Cir Vasc. 2002 [acceso 23/8/2020];3(1):21-5. Disponible en: http://bvs.sld.cu/revistas/ang/vol3_1_02/angsu102.htm
Keely Boyle K, Rachala S, Nodzo SR. Centers for disease control and prevention 2017 guidelines for prevention of surgical site infections: review and relevant recommendations. Curr Rev Musculoskelet Med. 2018;11:357-69. DOI: https://doi.org/10.1007/s12178-018-9498-8
Koch AM, Nilsen RM, Eriksen HM, Cox RJ, Harthug S. Mortality related to hospital-associated infections in a tertiary hospital; repeated cross-sectional studies between 2004-2011. Antimicrob Resist Infect Control. 2015;4:57-63. DOI: http://dx.doi.org/10.1186/s13756-015-0097-9
Galván-Meléndez MF, Castañeda-Martínez LY, Galindo-Burciaga M, Morales-Castro ME. Infections associated with healthcare and antimicrobial resistance. Rev Esp Méd Quir. 2017 Jan [acceso 22/06/2019];22(1):1-13. Disponible en: http://www.redalyc.org/articulo.oa?id=47350389001
Koch AM, Nilsen RM, Dalheim A, Cox RJ, Harthug S. Need for more targeted measures-only less severe hospital-associated infections declined after introduction of an infection control program. J Infect Public Health. 2015;8(3):282-90. DOI: http://dx.doi.org/10.1016/j.jiph.2014.11.001
Jefferson J, Mermel LA. Coordination of infection control activities at the health care system level. Survey results. Infect Control Hosp Epidemiol. 2018 Jan;39(1):121-2. DOI: http://dx.doi.org/10.1017/ice.2017.257
Baker MA, Huang SS, Letourneau AR, Kaganov RE, Peeples JR, Drees M, Platt R, Yokoe DS. Lack of comprehensive outbreak detection in hospitals. Infect Control Hosp Epidemiol. 2016 Apr;37(4):466-8. DOI: http://dx.doi.org/10.1017/ice.2015.325
Arnoldo L, Smaniotto C, Celotto D, et al. Monitoring healthcare-associated infections and antimicrobial use at regional level through repeated point prevalence surveys: what can be learnt? J Hosp Infect. 2019;101(4):447-54. DOI: http://dx.doi.org/10.1016/j.jhin.2018.12.016
World Medical Association (WMA). Declaration of Helsinki. Ethical principles for medical research involving human subjects. 64th World Medical Association General Assembly. Fortaleza, Brazil, October 2013. Updated Helsinki guidelines for clinical research get mixed reviews. JAMA. 2013. DOI: http://dx.doi.org/10.1001/jama.2013.281053
Coello R. Prevalencia de las infecciones nosocomiales en los Hospitales Españoles EPINE 1990--1994. Clinic Microbiolol Infect. 1996 Aug;2(1):70. DOI: https://doi.org/10.1111/j.1469-0691.1996.tb00206.x
Zamudio-Lugo I, Espinosa-Vital GJ, Rodríguez-Sing R, Gómez-González CJ, Miranda-Novalesb MG. Infecciones nosocomiales tendencia durante 12 años en un hospital pediátrico. Rev Med Inst Mex Seguro Soc. 2014 [acceso 22/06/2019];52(Supl 2):S38-42. Disponible en: http://www.redalyc.org/articulo.oa?id=457745486007
Cai Y, Venkatachalam I, Tee NW. Prevalence of healthcare associated infections and antimicrobial use among adult in patients in Singapore acute care hospitals: Results from the first national point prevalence survey. Clin Infect Dis. 2017;64(suppl 2):S61-7. DOI: http://dx.doi.org/10.1093/cid
Cassini A, Plachouras D, Eckmanns T. Burden of six healthcare associated infections on european population health: estimating incidence-based disability-adjusted life years through a population prevalence based modeling study. PLoS Med. 2016 [acceso 22/06/2019];13(10):e1002150. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068791/pdf/pmed.1002150.pdf
Puentes Madera IC, Rubio Medina Y, Gallardo Pérez U. Incidencia de la sepsis del sitio quirúrgico en el Instituto Nacional de Angiología y Cirugía Vascular 2000-2005. Rev Cubana Invest Bioméd. 2008 [acceso 23/8/2020];27(2). Disponible en: http://scielo.sld.cu/pdf/ibi/v27n2/ibi08208.pdf
Rodríguez Camacho E, Díaz García B. Infecciones-colonizaciones por gérmenes multirresistentes. Galicia Clin. 2014 [acceso 22/06/2020];75(1):17-21. Disponible en: https://www.semanticscholar.org/paper/Infecciones%2Fcolonizaciones-por-G%C3%A9rmenes-Camacho-Garc%C3%ADa/3551025e6ced061f0b54c5bde6827bc0992e1c33#paper-header
Álvarez López A. Respuesta al tratamiento con Heberprot-P(r) según la severidad de la enfermedad arterial periférica. Rev Cubana Angiol Cir Vasc. 2016 Dic [acceso 13/8/2020];17(2):130-7. Disponible en: http://scielo.sld.cu/scielo.0037201600020000
Jay Cordies B, Sánchez Hechavarria Z, Kindelán Mesa L, Cámbara Toro Y. Buenas prácticas clínicas con el uso del Heberprot-P(r) en pacientes con úlcera del pie diabético. Rev Cubana Enferm. 2019 [acceso 13/8/2020];35(2). Disponible en: http://www.revenfermeria.sld.cu/index.php/enf/article/view/1701
Fabelo Martínez A, Figueroa Martínez A, Valdés Pérez C, Pérez Leonard D, Álvarez López A. Evolución de las úlceras de pie diabético con el tratamiento mixto de Heberprot-P(r) y ozonoterapia. Rev Cubana Angiol Cir Vasc. 2019 Jun [acceso 13/8/2020];20(1):e378. Disponible en: http://revangiologia.sld.cu/index.php/ang/article/view/37/16
Romero Sánchez RE, Landín Sorí M, García Rodríguez M. Actualidad en infecciones quirúgicas. Rev Arch med Camagüey. 2012 [acceso 23/8/2020];16(4):1507-17. Disponible en: http://scielo.sld.cu/pdf/amc/v16n4/amc150412.pdf
Keely Boyle K, Rachala S, Nodzo SR. Centers for disease control and prevention 2017 guidelines for prevention of surgical site infections: review and relevant recommendations. Curr Rev Musculoskelet Med. 2018;11:357-69. DOI: https://doi.org/10.1007/s12178-018-9498-8
Almeida GC, dos Santos MM, Lima NG, Cidral TA, Melo MC, Lima KC. Prevalence and factors associated with wound colonization by Staphylococcus spp. and Staphylococcus aureus in hospitalized patients in Inland Northeastern Brazil: a cross-sectional study. BMC Infect Dis. 2014 [acceso 13/5/2020];14:(1). Disponible en: https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-14-328
Serra R, Grande R, Butrico L, Rossi A, Settimio UF, Caroleo B, et al. Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus. Exp Rev Anti-infec Ther. 2015;13(5):605-13. DOI: https://doi.org/10.1586/14787210.2015.1023291
Georgescu M, Gheorghe I, Curutiu C, Lazar V, Bleotu C, Chifiriuc MC. Virulence and resistance features of Pseudomonas aeruginosa strains isolated from chronic leg ulcers. BMC infectious diseases. 2016;16(1):92. DOI: https://doi.org/10.1186/s12879-016-1396-3